The Epoch Times The Department of Health and Human Services (HHS) began to limit the distribution of the antibody therapy for COVID-19 on Sept. 3 to address a surge in demand for the treatment.
The department immediately limited orders only to sites that report their utilization of the monoclonal therapy to the government, according to a notice. The HHS is also vetting all orders against the rate at which the sites are utilizing the allotted doses.
The notice states that the change is temporary.
Daily News PDF Archives – Jellyfish.News